Author:
Zhang Wenting,Fan Wei,Rachagani Satyanarayana,Zhou Zhengyuan,Lele Subodh M.,Batra Surinder K.,Garrison Jered C.
Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Patel, O., Shulkes, A. & Baldwin, G. S. Gastrin-releasing peptide and cancer. Biochim Biophys Acta 1766, 23–41 (2006).
2. Van de Wiele, C. et al. Biodistribution and dosimetry of 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J Nucl Med 42, 1722–1727 (2001).
3. Van de Wiele, C. et al. Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study. Eur J Nucl Med 27, 1694–1699 (2000).
4. Minamimoto, R. et al. Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med 57, 557–562 (2016).
5. Zhang, J. et al. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients. J Nucl Med 59, 922–928 (2018).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献